Enovis Corp
ENOV32.166USD
+0.586+1.85%
Market hours （ET）Quotes delayed by 15 min
1.84BMarket Cap
LossP/E TTM
More Details of Enovis Corp Company
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment develops, manufactures, and distributes rigid bracing products, orthopedic soft goods, vascular systems and compression garments, and hot and cold therapy products and offers recovery sciences products in the clinical rehabilitation and sports medicine markets, such as bone growth stimulators and electrical stimulators used for pain management. The Reconstructive segment develops, manufactures, and markets a variety of knee, hip, shoulder, elbow, foot, ankle, and finger implant products and surgical productivity tools. It also provides Novastep, a minimally invasive surgery (MIS) foot and ankle solutions.
Company Info
Ticker SymbolENOV
Company nameEnovis Corp
IPO dateMay 08, 2008
CEOMr. Damien Mcdonald
Number of employees7367
Security typeOrdinary Share
Fiscal year-endMay 08
Address2711 Centerville Road
CityWILMINGTON
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code19808
Phone13022529160
Websitehttps://www.enovis.com/
Ticker SymbolENOV
IPO dateMay 08, 2008
CEOMr. Damien Mcdonald
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Daniel Alexis Pryor
Mr. Daniel Alexis Pryor
Executive Vice President - Strategy and Business Development
Executive Vice President - Strategy and Business Development
114.51K
+9.57%
Mr. Damien Mcdonald
Mr. Damien Mcdonald
Chief Executive Officer, Director
Chief Executive Officer, Director
96.30K
--
Mr. Terry D. Ross
Mr. Terry D. Ross
Group President - Prevention and Recovery
Group President - Prevention and Recovery
35.79K
-0.90%
Ms. Sharon L. Wienbar
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
28.26K
+30.46%
Mr. Rajiv Vinnakota
Mr. Rajiv Vinnakota
Independent Director
Independent Director
20.37K
+47.89%
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Independent Director
Independent Director
15.27K
+76.12%
Ms. Barbara W. Bodem
Ms. Barbara W. Bodem
Independent Director
Independent Director
10.52K
+168.36%
Dr. Christine Ortiz, Ph.D.
Dr. Christine Ortiz, Ph.D.
Independent Director
Independent Director
10.52K
+168.36%
Mr. Philip A. Okala
Mr. Philip A. Okala
Independent Director
Independent Director
--
--
Ms. Angela S. Lalor
Ms. Angela S. Lalor
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Daniel Alexis Pryor
Mr. Daniel Alexis Pryor
Executive Vice President - Strategy and Business Development
Executive Vice President - Strategy and Business Development
114.51K
+9.57%
Mr. Damien Mcdonald
Mr. Damien Mcdonald
Chief Executive Officer, Director
Chief Executive Officer, Director
96.30K
--
Mr. Terry D. Ross
Mr. Terry D. Ross
Group President - Prevention and Recovery
Group President - Prevention and Recovery
35.79K
-0.90%
Ms. Sharon L. Wienbar
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
28.26K
+30.46%
Mr. Rajiv Vinnakota
Mr. Rajiv Vinnakota
Independent Director
Independent Director
20.37K
+47.89%
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Independent Director
Independent Director
15.27K
+76.12%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
International Reconstructive
148.37M
26.55%
U.S. Reconstructive
137.88M
24.67%
U.S. Bracing & Support
115.09M
20.59%
International P&R
90.88M
16.26%
U.S. Other P&R
66.62M
11.92%
No Data
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
International Reconstructive
148.37M
26.55%
U.S. Reconstructive
137.88M
24.67%
U.S. Bracing & Support
115.09M
20.59%
International P&R
90.88M
16.26%
U.S. Other P&R
66.62M
11.92%
Shareholding Stats
Updated: Tue, Aug 19
Updated: Tue, Aug 19
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
14.03%
The Vanguard Group, Inc.
11.14%
American Century Investment Management, Inc.
8.29%
Dimensional Fund Advisors, L.P.
5.11%
Davenport Asset Management
4.82%
Other
56.62%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
14.03%
The Vanguard Group, Inc.
11.14%
American Century Investment Management, Inc.
8.29%
Dimensional Fund Advisors, L.P.
5.11%
Davenport Asset Management
4.82%
Other
56.62%
Shareholder Types
Shareholders
Proportion
Investment Advisor
61.34%
Investment Advisor/Hedge Fund
37.68%
Hedge Fund
14.15%
Research Firm
5.57%
Individual Investor
1.58%
Bank and Trust
1.27%
Pension Fund
1.11%
Venture Capital
0.13%
Sovereign Wealth Fund
0.05%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
641
62.33M
109.11%
-9.18M
2025Q1
646
68.39M
119.73%
-3.70M
2024Q4
637
64.20M
113.02%
-5.55M
2024Q3
613
62.53M
111.92%
-6.94M
2024Q2
617
64.91M
118.38%
-5.04M
2024Q1
651
62.70M
114.40%
-9.13M
2023Q4
661
61.64M
112.95%
-6.99M
2023Q3
653
60.52M
110.96%
-10.76M
2023Q2
641
59.95M
109.96%
-8.07M
2023Q1
643
57.38M
105.33%
-9.99M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
6.52M
11.41%
+1.67M
+34.39%
Mar 31, 2025
The Vanguard Group, Inc.
6.08M
10.64%
-7.15K
-0.12%
Mar 31, 2025
American Century Investment Management, Inc.
3.52M
6.17%
+369.48K
+11.71%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
2.93M
5.12%
+27.89K
+0.96%
Mar 31, 2025
Davenport Asset Management
3.07M
5.38%
-206.82K
-6.31%
Mar 31, 2025
State Street Global Advisors (US)
1.89M
3.32%
+162.41K
+9.37%
Mar 31, 2025
Royce Investment Partners
2.49M
4.36%
+20.23K
+0.82%
Mar 31, 2025
Hood River Capital Management LLC
1.44M
2.53%
+781.15K
+118.10%
Mar 31, 2025
River Road Asset Management, LLC
1.39M
2.44%
+153.53K
+12.40%
Mar 31, 2025
View more
Related ETFs
Updated: Wed, Aug 6
Updated: Wed, Aug 6
Name
Proportion
SPDR S&P Health Care Equipment ETF
1.72%
Invesco S&P SmallCap Health Care ETF
1.03%
Invesco S&P SmallCap 600 Pure Value ETF
0.5%
VictoryShares US Small Mid Cap Value Momentum ETF
0.31%
SPDR S&P 600 Small Cap Value ETF
0.28%
First Trust Small Cap Growth AlphaDEX Fund
0.27%
iShares S&P Small-Cap 600 Value ETF
0.24%
Avantis US Small Cap Equity ETF
0.21%
iShares U.S. Medical Devices ETF
0.2%
SPDR S&P SmallCap 600 ESG ETF
0.19%
View more
SPDR S&P Health Care Equipment ETF
Proportion1.72%
Invesco S&P SmallCap Health Care ETF
Proportion1.03%
Invesco S&P SmallCap 600 Pure Value ETF
Proportion0.5%
VictoryShares US Small Mid Cap Value Momentum ETF
Proportion0.31%
SPDR S&P 600 Small Cap Value ETF
Proportion0.28%
First Trust Small Cap Growth AlphaDEX Fund
Proportion0.27%
iShares S&P Small-Cap 600 Value ETF
Proportion0.24%
Avantis US Small Cap Equity ETF
Proportion0.21%
iShares U.S. Medical Devices ETF
Proportion0.2%
SPDR S&P SmallCap 600 ESG ETF
Proportion0.19%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Date
Type
Ratio
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
